Manipal sweetens bid for Fortis

MEHL to infuse ₹2,100 crore into Fortis Healthcare

May 06, 2018 10:08 pm | Updated 10:08 pm IST - CHENNAI

A Fortis hospital building is pictured through a fence in New Delhi, India, March 28, 2018. REUTERS/Adnan Abidi

A Fortis hospital building is pictured through a fence in New Delhi, India, March 28, 2018. REUTERS/Adnan Abidi

The consortium of Manipal Health Enterprises (MHEPL) and private equity firm TPG Asia has again revised the offer for Fortis Healthcare.

The consortium now proposed to infuse ₹2,100 crore into the company at ₹160 per share.

The combine also proposed to merge MHEPL with Fortis Healthcare, valuing the latter at ₹8,358 crore.

Earlier, the bidders had proposed a demerger of the hospital business of Fortis, which it valued at ₹6,322 crore as on April 24.

This business is to be subsequently merged with Manipal Hospitals, which has now been valued at ₹6,070 crore, according to a filing.

Manipal-TPG informed Fortis that it would infuse the ₹2,100 crore into FHL through preferential allotment. The proceeds, it said, would be used to repay existing loans, fund working capital requirements and partly finance the acquisition of relevant Indian entities from Religare Health Trust (RHT). To supervise the use of these proceeds, Manipal-TPG has sought the right to appoint “such number of non-executive directors pro rata to its shareholding after the preferential allotment (with a fractional number being rounded up to the nearest whole number) subject to the FHL board comprising a minimum of seven directors. This preferential allotment is subject to regulatory, shareholder and other relevant approvals.

Immediate liquidity

The preferential allotment, the consortium said, was being undertaken only to provide immediate liquidity to Fortis by way of a minority investment in the company.

“The preferential allotment and the ability to appoint directors as aforesaid, shall not vest control in the subscriber(s) and, accordingly, no open offer is required to be made,” said the consortium.

Manipal-TPG’s proposal to merge MHEPL into FHL values Fortis at ₹8,358 crore and MHEPL at ₹6,070 crore.

“A value of ₹8,358 crores for FHL shall translate into a per share value of ₹160 per equity share (being the same price per equity share as offered for the preferential allotment),” the consortium said.

To resolve obligation of Fortis to provide an exit to SRL PE investors, the combine proposed to purchase their stake subject to agreement with the PE investors.

As with their earlier offers, the consortium has proposed to purchase PE investors’ 30.93% stake in SRL, Fortis Healthcare’s (FHL) diagnostics arm, for ₹1,113.4 crore.

Post the acquisition of the PE SRL stake, the SRL board will be restructured “so as to ensure that no member of the promoter group of FHL is part of the SRL board,” it said.

The Fortis board will meet on May 10 to take a call on these offers based on the recommendations of an expert committee set up by it.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.